Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1099125.RAMtj7R6U-XL67hIfPReiN1bx26Ucp7nTgUSiJXU860J0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1099125.RAMtj7R6U-XL67hIfPReiN1bx26Ucp7nTgUSiJXU860J0130_assertion type Assertion NP1099125.RAMtj7R6U-XL67hIfPReiN1bx26Ucp7nTgUSiJXU860J0130_head.
- NP1099125.RAMtj7R6U-XL67hIfPReiN1bx26Ucp7nTgUSiJXU860J0130_assertion description "[Enzastaurin before and concomitant with radiation therapy, followed by enzastaurin maintenance therapy, in patients with newly diagnosed glioblastoma without MGMT promoter hypermethylation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1099125.RAMtj7R6U-XL67hIfPReiN1bx26Ucp7nTgUSiJXU860J0130_provenance.
- NP1099125.RAMtj7R6U-XL67hIfPReiN1bx26Ucp7nTgUSiJXU860J0130_assertion evidence source_evidence_literature NP1099125.RAMtj7R6U-XL67hIfPReiN1bx26Ucp7nTgUSiJXU860J0130_provenance.
- NP1099125.RAMtj7R6U-XL67hIfPReiN1bx26Ucp7nTgUSiJXU860J0130_assertion SIO_000772 23911595 NP1099125.RAMtj7R6U-XL67hIfPReiN1bx26Ucp7nTgUSiJXU860J0130_provenance.
- NP1099125.RAMtj7R6U-XL67hIfPReiN1bx26Ucp7nTgUSiJXU860J0130_assertion wasDerivedFrom befree-2016 NP1099125.RAMtj7R6U-XL67hIfPReiN1bx26Ucp7nTgUSiJXU860J0130_provenance.
- NP1099125.RAMtj7R6U-XL67hIfPReiN1bx26Ucp7nTgUSiJXU860J0130_assertion wasGeneratedBy ECO_0000203 NP1099125.RAMtj7R6U-XL67hIfPReiN1bx26Ucp7nTgUSiJXU860J0130_provenance.